Assessment of the Ability to Distinguish Odors in Glaucoma Patients
Olfactory Function in Glaucoma Patients
1 other identifier
observational
30
0 countries
N/A
Brief Summary
Glaucoma is one of the leading causes of blindness worldwide. The key feature of glaucoma is damage to the optic nerve head with loss of retinal ganglion cells and local tissue remodeling. Neuronal cell death in glaucoma occurs by apoptotic mechanisms1. Apoptosis of neurons also plays a major role in neurodegenerative diseases, such as Alzheimer's or Parkinson's disease. An association between glaucoma and these disorders has been described 2-4. Furthermore, it has been reported that the olfactory function is disturbed in these neurodegenerative diseases5-6. We hypothesize that similar olfactory alterations may occur in glaucoma which is in fact a local neurodegenerative disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2004
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
March 17, 2006
CompletedFirst Posted
Study publicly available on registry
March 20, 2006
CompletedSeptember 26, 2008
September 1, 2008
March 17, 2006
September 25, 2008
Conditions
Keywords
Eligibility Criteria
glaucoma patients
You may qualify if:
- Chronic open-angle glaucoma with typical glaucomatous disc and visual field damage.
You may not qualify if:
- Occludable iridocorneal angles
- History of current, chronic or recurrent inflammatory eye disease
- History of retinal or neuroophthalmologic disease that could result in visual field defects
- Need for any concomitant medications that may interfere with the evaluation of olfactory function
- Patients with a significant history and/or active alcohol or drug abuse (significant is defined as that which in the opinion of the investigator may either put the patient at risk because of participation in the study or may influence the results of the study or the patient's ability to participate in the study), smokers
- History of olfactory disturbance related to identifiable local factors and any local condition that could lead to hyposmia/anosmia or interfere with the olfactory function, such as polyps, chronic sinus infection, sub(acute) viral or bacterial infection, history of sinus surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Selim Orgul
University Eye Hospital Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 17, 2006
First Posted
March 20, 2006
Study Start
October 1, 2004
Study Completion
November 1, 2005
Last Updated
September 26, 2008
Record last verified: 2008-09